Prediction of [sup.177]Lu-DOTATATE Therapy Outcomes in Neuroendocrine Tumor Patients Using Semi-Automatic Tumor Delineation on [sup.68]Ga-DOTATATE PET/CT

[sup.177]Lu-DOTATATE is a radioactive drug that can treat advanced neuroendocrine tumors, a type of cancer. However, some patients do not benefit from [sup.177]Lu-DOTATATE treatment and there is an unmet need to identify such patients before they receive the treatment. Currently, each patient needs...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Cancers 2023-12, Vol.16 (1)
Hauptverfasser:	Lee, Hwan, Kipnis, Sarit T, Niman, Remy, O’Brien, Sophia R, Eads, Jennifer R, Katona, Bryson W, Pryma, Daniel A
Format:	Artikel
Sprache:	eng
Schlagworte:	Care and treatment Development and progression Patient outcomes PET imaging Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!